Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SH) awarded 1.6 million restricted shares to 93 incentive recipients.
Jibeir (688566.SH) announced that the company held the twentieth meeting of the fourth board of directors on April 10, 2026, and approved the Proposal on Adjusting the Restricted Stock Incentive Plan Grant Price for 2025 and the Proposal on Granting Reserved Restricted Stock to Participants in the 2025 Restricted Stock Incentive Plan. The board agreed to reserve the restricted stock grant date for this incentive plan on April 10, 2026, and approved the granting of 1.6 million shares of restricted stock to 93 incentive recipients at a price of 11.62 yuan per share.
Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SH) announced that the company held its twentieth meeting of the fourth session of the board of directors on April 10, 2026. The board approved the proposal to adjust the grant price of restricted shares for the Company's 2025 Restricted Stock Incentive Plan, as well as the proposal to reserve restricted shares for the incentive objects of the Company's 2025 Restricted Stock Incentive Plan. The board agreed that the date for granting the reserved restricted shares under this incentive plan would be April 10, 2026, and approved the grant of 1.6 million shares of restricted stock to 93 incentive objects at a price of 11.62 yuan per share.
Related Articles
US Stock Market Move | Signed computing power lease agreement with Anthropic, CoreWeave (CRWV.US) opened trading with over 4% increase.
BEISEN HOLDING (09669) subscribed to 30 million yuan worth of financial products.
On April 10th, JXR (01951) spent 7.889 million Hong Kong dollars to repurchase 3.2 million shares.
US Stock Market Move | Signed computing power lease agreement with Anthropic, CoreWeave (CRWV.US) opened trading with over 4% increase.
BEISEN HOLDING (09669) subscribed to 30 million yuan worth of financial products.
On April 10th, JXR (01951) spent 7.889 million Hong Kong dollars to repurchase 3.2 million shares.
RECOMMEND
